Q1 2025 Holdings
Filed 2025-05-15 | 34 holdings | $86.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ocular Therapeutix Inc(OCUL) | COM | 67576A100 | $8.9M | 1,219,724 | 10.4% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $8.1M | 106,074 | 9.4% |
| Tourmaline BIO Inc(TRML) | COM | 89157D105 | $6.5M | 426,882 | 7.5% |
| Whitehawk Therapeutics Inc(WHWK) | COM | 00032Q104 | $6.1M | 3,410,402 | 7.0% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $5.2M | 265,269 | 6.1% |
| Trevi Therapeutics Inc(TRVI) | COM | 89532M101 | $4.9M | 785,961 | 5.7% |
| Soleno Therapeutics Inc(SLNO) | COM | 834203309 | $4.8M | 67,136 | 5.6% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $4.2M | 7,023 | 4.8% |
| Ascendis PHA(ASND) | SPONSORED ADR | 04351P101 | $3.6M | 23,340 | 4.2% |
| Praxis Precision Medicines I(PRAX) | COM | 74006W207 | $3.3M | 87,141 | 3.8% |
| Cidara Therapeutics Inc(CDTX) | COM NEW | 171757206 | $2.7M | 125,708 | 3.1% |
| Oculis Holding AG(OCS) | ORDINARY SHARES | H5870P102 | $2.4M | 125,000 | 2.8% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $2.4M | 66,662 | 2.7% |
| Liquidia Corporation(LQDA) | COM NEW | 53635D202 | $2.3M | 153,482 | 2.6% |
| Bright Minds Biosciences Inc(DRUG) | COM NEW | 10919W405 | $2.2M | 59,748 | 2.5% |
| Helix Acquisition Corp II | CL A ORD SHS | G4444H101 | $2.1M | 187,257 | 2.5% |
| Merck & Co(MRK) | COM | 58933Y105 | $2.1M | 22,994 | 2.4% |
| Surrozen Inc(SRZN) | COM NEW | 86889P208 | $2.0M | 170,000 | 2.3% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $1.9M | 85,454 | 2.2% |
| Mereo Biopharma Group PL(MREO) | SPON ADS | 589492107 | $1.8M | 791,815 | 2.1% |
| Unicycive Therapeutics Inc | COM | 90466Y103 | $1.4M | 2,352,887 | 1.6% |
| Jazz Pharmaceuticals PLC(JAZZ) | SHS USD | G50871105 | $1.2M | 9,575 | 1.4% |
| Verastem Inc(VSTM) | COM NEW | 92337C203 | $1.1M | 176,000 | 1.2% |
| Gilead Sciences Inc(GILD) | COM | 375558103 | $1.0M | 9,298 | 1.2% |
| Terns Pharmaceuticals Inc(TERN) | COM | 880881107 | $898.5K | 325,550 | 1.0% |
| Zymeworks Inc(ZYME) | COM | 98985Y108 | $815.3K | 68,459 | 0.9% |
| Ultragenyx Pharmaceutical Inc(RARE) | COM | 90400D108 | $770.9K | 21,290 | 0.9% |
| Verve Therapeutics Inc | COM | 92539P101 | $743.6K | 162,724 | 0.9% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $555.9K | 83,350 | 0.6% |
| Rapport Therapeutics Inc(RAPP) | COM | 75383L102 | $164.5K | 16,400 | 0.2% |
| Forte Biosciences Inc(FBRX) | COM NEW | 34962G208 | $143.3K | 18,469 | 0.2% |
| Artiva Biotherapeutics Inc(ARTV) | COM | 04317A107 | $136.4K | 45,456 | 0.2% |
| Nuvation BIO Inc -Cw27(NUVB/WS) | *W EXP 07/07/2027 | 67080N119 | $17.5K | 90,832 | 0.0% |
| Enliven Therapeutics Inc | COM | 452CVR012 | $0 | 115,805 | 0.0% |